Control of vector-borne infectious diseases by human immunity against α-Gal
Expert review of vaccines.
2016 Aug ;
15 (8) :
953-5.
[epub] 20160511
Language English Country England, Great Britain Media print-electronic
Document type Editorial, Research Support, Non-U.S. Gov't
Persistent link
https://www.medvik.cz/link/pmid27100121
- Keywords
- Microbiota, probiotics, vaccine, vector-borne diseases, α-Gal,
- MeSH
- Bacteria immunology MeSH
- Disaccharides immunology MeSH
- Disease Vectors * MeSH
- Communicable Diseases immunology therapy transmission MeSH
- Host-Pathogen Interactions MeSH
- Humans MeSH
- Evolution, Molecular MeSH
- Disease Transmission, Infectious prevention & control MeSH
- Probiotics therapeutic use MeSH
- Antibodies immunology MeSH
- Vaccines immunology therapeutic use MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Editorial MeSH
- Names of Substances
- Disaccharides MeSH
- galactosyl-(1-3)galactose MeSH Browser
- Antibodies MeSH
- Vaccines MeSH
c Department of Virology Veterinary Research Institute Brno Czech Republic
SaBio Instituto de Investigación de Recursos Cinegéticos IREC CSIC UCLM JCCM Ciudad Real Spain
References provided by Crossref.org
Immunity to α-Gal: The Opportunity for Malaria and Tuberculosis Control
Immunity to α-Gal: Toward a Single-Antigen Pan-Vaccine To Control Major Infectious Diseases
ACS central science.
2017 Nov 22 ;
3 (11) :
1140-1142.
[epub] 20171110
Oncotarget.
2017 Mar 28 ;
8 (13) :
20630-20644.
